The mechanism, clinical efficacy, safety, and dosage regimen of atomoxetine for ADHD therapy in children: a narrative review
D Fu, DD Wu, HL Guo, YH Hu, Y Xia, X Ji… - Frontiers in …, 2022 - frontiersin.org
Atomoxetine, a selective norepinephrine (NE) reuptake inhibitor, was approved for attention
deficit/hyperactivity disorder (ADHD) treatment in children, adolescents and adults. We …
deficit/hyperactivity disorder (ADHD) treatment in children, adolescents and adults. We …
Evaluation of methylphenidate safety and maximum-dose titration rationale in attention-deficit/hyperactivity disorder: a meta-analysis
C Ching, GD Eslick, AS Poulton - JAMA pediatrics, 2019 - jamanetwork.com
Importance Evidence on the titration of stimulant medications for attention-
deficit/hyperactivity disorder (ADHD) is lacking. However, this lack of evidence has not …
deficit/hyperactivity disorder (ADHD) is lacking. However, this lack of evidence has not …
Clinical and experimental factors influencing the efficacy of neurofeedback in ADHD: a meta-analysis
Meta-analyses have been extensively used to evaluate the efficacy of neurofeedback (NFB)
treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents …
treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents …
Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison
A Joseph, R Ayyagari, M Xie, S Cai, J Xie… - European child & …, 2017 - Springer
This study compared the clinical efficacy and safety of attention-deficit/hyperactivity disorder
(ADHD) pharmacotherapy in children and adolescents 6–17 years of age. A systematic …
(ADHD) pharmacotherapy in children and adolescents 6–17 years of age. A systematic …
Comparative efficacy and safety of methylphenidate and atomoxetine for attention-deficit hyperactivity disorder in children and adolescents: Meta-analysis based on …
Q Liu, H Zhang, Q Fang, L Qin - Journal of clinical and …, 2017 - Taylor & Francis
Introduction: Comparative efficacy and safety are important issues for appropriate drug
selection for attention-deficit hyperactivity disorder (ADHD) treatment. Therefore we …
selection for attention-deficit hyperactivity disorder (ADHD) treatment. Therefore we …
The effects of methylphenidate and atomoxetine on Drosophila brain at single-cell resolution and potential drug repurposing for ADHD treatment
S Qu, X Zhou, Z Wang, Y Wei, H Zhou, X Zhang… - Molecular …, 2023 - nature.com
The stimulant methylphenidate (MPH) and the non-stimulant atomoxetine (ATX) are
frequently used for the treatment of attention-deficit/hyperactivity disorder (ADHD); however …
frequently used for the treatment of attention-deficit/hyperactivity disorder (ADHD); however …
The association with quantitative response to attention-deficit/hyperactivity disorder medication of the previously identified neurodevelopmental network genes
Y Zhong, B Yang, Y Su, Y Qian, Q Cao… - Journal of Child and …, 2020 - liebertpub.com
Objective: A recent pharmacoimaging study suggested that methylphenidate (MPH) and
atomoxetine (ATX) might have common mechanisms for the treatment of attention …
atomoxetine (ATX) might have common mechanisms for the treatment of attention …
Efficacy and tolerability of different interventions in children and adolescents with attention deficit hyperactivity disorder
R Luan, Z Mu, F Yue, S He - Frontiers in psychiatry, 2017 - frontiersin.org
Background Our study is an analysis of multiple publications involving assessing the
comparable efficacy and tolerability of six interventions, which are lisdexamfetamine …
comparable efficacy and tolerability of six interventions, which are lisdexamfetamine …
Osmotic Release Oral System-Methylphenidate Hydrochloride (OROS-MPH) versus atomoxetine on executive function improvement and clinical effectiveness in …
Y Taş Torun, Y Işik Taner, E Güney… - Applied …, 2022 - Taylor & Francis
Objectives The aim of this study to compare the clinic efficacy and effects of osmotic release
oral system-methylphenidate and atomoxetine on executive function in children and …
oral system-methylphenidate and atomoxetine on executive function in children and …
[HTML][HTML] The alpha-2A adrenergic receptor gene-1291C/G single nucleotide polymorphism is associated with the efficacy of methylphenidate in treating Taiwanese …
HC Huang, LSH Wu, SC Yu, BJ Wu, AC Lua… - Psychiatry …, 2018 - ncbi.nlm.nih.gov
Objective The therapeutic effect of methylphenidate (MPH) in treating attention-
deficit/hyperactivity disorder (ADHD) has been related to the alpha-2A adrenergic receptor …
deficit/hyperactivity disorder (ADHD) has been related to the alpha-2A adrenergic receptor …